Max Robotics — Global Service Robot Directory + US Certification

About

Tomohiro Matsuo is a urologic surgeon and researcher whose work centers on improving surgical outcomes for prostate and kidney cancers, with a particular focus on robot-assisted and minimally invasive techniques. His most impactful research addresses the pressing clinical challenge of predicting lymph node invasion and biochemical recurrence (BCR) in high-risk prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). In a 2022 study with 12 citations, he identified preoperative predictors of pathological lymph node metastasis and postoperative BCR, providing critical guidance for surgical planning and patient counseling. His 2024 work, with 8 citations, further refines risk stratification by pinpointing factors that predict early BCR within two years of RARP, enabling more personalized postoperative surveillance. Beyond prostate cancer, Matsuo has contributed to nephron-sparing surgery, demonstrating in a 2022 study how laparoscopic and robot-assisted partial nephrectomy preserve split renal function—a key measure of kidney health. His initial experience with robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy, though early in citation impact, showcases his pioneering role in tackling complex, high-morbidity renal cell carcinoma cases. Through these contributions, Matsuo is advancing precision in urologic oncology, helping surgeons tailor interventions to individual patient risk profiles.